Top-line data from Part B of phase 3 RINGSIDE study, using AL102 for the treatment of patients with desmoid tumors, expected 2nd half of 2025.The global desmoid tumor market is projected to grow to $...
Source LinkTop-line data from Part B of phase 3 RINGSIDE study, using AL102 for the treatment of patients with desmoid tumors, expected 2nd half of 2025.The global desmoid tumor market is projected to grow to $...
Source Link
Comments